LIFECORE BIOMEDICAL, INC. (LFCR) Shareholders’ equity 2016–2025
LIFECORE BIOMEDICAL, INC. (LFCR) shareholders’ equity at each fiscal year-end, per SEC filings.
$1.3MFY2025 · since FY2016: $210.7M → $1.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.3M | -88.2% |
| FY2024 | $11.3M | +367.5% |
| FY2023 | -$4.2M | -104.8% |
| FY2022 | $87.8M | -56.5% |
| FY2021 | $201.9M | -12.1% |
| FY2020 | $229.8M | -14.9% |
| FY2019 | $270.1M | +7.0% |
| FY2018 | $252.6M | +11.5% |
| FY2017 | $226.6M | +7.5% |
| FY2016 | $210.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice